Lumigan and Pepcid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lumigan (bimatoprost) and Pepcid (famotidine). Common drug interactions include pain among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Lumigan and Pepcid. It is created by eHealthMe based on reports of 130 people who take the same drugs from the FDA, and is updated regularly.
What is Lumigan?
Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.
What is Pepcid?
Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,775 Pepcid users. Check the latest studies of Pepcid.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
130 people who take Lumigan and Pepcid together, and have interactions are studied.
What are the common drug interactions of Lumigan and Pepcid, by gender? *
What are the common drug interactions of Lumigan and Pepcid, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Lumigan and Pepcid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lumigan and Pepcid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lumigan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pepcid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lumigan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pepcid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bimatoprost and famotidine (the active ingredients of Lumigan and Pepcid, respectively), and Lumigan and Pepcid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tricor cause Cardiogenic Shock? - a second ago
- Could Loratadine cause Nasal Dryness? - 2 seconds ago
- Could Fentanyl-50 cause Nausea? - 4 seconds ago
- Could Loratadine cause Cardiac Failure Chronic? - 6 seconds ago
- Could Loratadine cause Acute Myeloid Leukaemia Aggravated? - 7 seconds ago
- Could Nitrol cause Ventricular Extrasystoles? - 17 seconds ago
- Could Camptosar cause Appetite - Decreased? - 20 seconds ago
- Could Camptosar cause Appetite Decreased? - 20 seconds ago
- Could Pravastatin Sodium cause Echocardiogram Abnormal? - 21 seconds ago
- Could Lopressor cause Tuberculosis? - 25 seconds ago